1998 Annual Meeting

Tuesday, June 2

7 a.m.-8:30 a.m.

Industry-Supported Symposium

IS34. Practical Clinical Strategies for Managing Depression, Agitation, and Antidepressant Side Effects: Practical Strategies for Managing Sleep Disturbances and Sexual Dysfunction When Treating Depressed Patients Supported by Bristol-Myers Squibb
A. Managing Sleep Disturbances When Treating Depressed Patients Michael E. Thase, M.D.
B. Management of Antidepressant-Induced Sexual Dysfunction Anthony J. Rothschild, M.D.

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 59-64

9 a.m.-10:30 a.m.

Discussion Groups

5.ilip R. Muskin, M.D., atients Who Deny Medical Illness or Refuse Treatment
6. los Blanco-Jerez, M.D.,Mentorship

Lectures

L10. To Be AnnouncedProfessor Arthur R. Miller, APA's Patient Advocacy Award Lecture.
L11. The Course of Common Mental Disorders: Vulnerability, Destabilization, and Restitution Sir David Paul Goldberg, APA's Adolf Meyer Award Lecture.

Master Educator Clinical Consultations

5. James L. Griffith, M.D., on Patients With Symptoms of Somatization (Open to APA members only.)
6. Robert E. Hales, M.D., on The Treatment of Agitations and Aggression in Neuropsychiatric Patients (Open to APA members only.)

New Research Oral/Slide Sessions

Round Table Discussion

Coercion in Moderator: Robert Michels, M.D. .

Component Workshops

CW18. The New Social Security Income Rule for Children: Practical Issues APA Committee on Chronically Ill and Emotionally Handicapped Children Chairperson: Graeme Hanson, M.D. .
CW19. Recruitment and Retention APA Membership Committee Chairperson: Bernard A. Katz, M.D. .
CW20. Advances in Veterans Affairs Schizophrenia Research APA Consortium on Organized Service Systems Co-Chairpersons: Laurent S. Lehmann, M.D., and Frederick G. Guggenheim, M.D. .
CW21. Certification in Psychiatric Administration APA Committee on Psychiatric Administration and Management Co-Chairpersons: William H. Reid, M.D., and Carmel A. Foley, M.D. .
CW22. Access to Patients: Are Residents Being Carved Out? APA GlaxoWellcome Fellows Chairperson: Diana R. Sanderson, M.D. .
CW23. Current Issues in Medical Student Education APA Committee on Medical Student Education Co-Chairpersons: Michael J. Vergare, M.D., and Ronald L. Martin, M.D. .
CW24. Successful Practice in Long-Term Care APA Committee on Long-Term Care and Treatment for the Elderly Co-Chairpersons: George Dyck, M.D., and Gary S. Moak, M.D. .
CW25. The History of Managed Care in Psychiatry APA Committee on History and Library Co-Chairpersons: Etham S. Rofman, M.D., and Dilip Ramchandani, M.D. .
CW26. Women Psychiatrists: Their Triumphs and Tragedies APA Committee of Asian-American Psychiatrists, APA Committee on Women, and APA Committee on Religion and Psychiatry Co-Chairpersons: Geetha Jayaram, M.D., and C. Deborah Cross, M.D. .
CW27. Medical Manpower Issues: Are IMG's Scapegoats? APA Committee on International Medical Graduates Chairperson: Jambur V. Ananth, M.D. .

Issue Workshops

IW31. Dynamic Therapy With Self-Destructive Borderline Patients Chairperson: Eric M. Plakun, M.D. .
IW32. Video Case Studies of Couples in Treatment Chairperson: Ian E. Alger, M.D. .
IW33. JCAHO and HCFA Accreditation and Quality Care Co-Chairpersons: Roger L. Coleman, M.D. .
, and Richard L. Elliott, M.D. IW34. Creating and Using Addiction Treatment Guidelines, Continued Chairperson: Richard J. Frances, M.D. .
IW35. Update on Mental Health in the Oregon Health Plan Chairperson: David A. Pollack, M.D. .
IW36. Facing Television Violence in Clinical Practice Chairperson: Paul A. Kettl, M.D. .
IW37. Swimming With the Sharks Chairperson: Michelle Riba, M.D. .
IW38. ABPN Examinations and Canadians Joint Session With the American Board of Psychiatry and Neurology Inc and APA Board of Trustees Chairperson: Michael F. Myers, M.D. .
IW39. Cognitive Therapy for Personality Disorders Chairperson: Judith S. Beck, Ph.D. .
IW40. The Standardized Patient in Psychiatric Education Chairperson: Susan E. Abbey, M.D. .
IW41. Predatory Abuse: Exploitation of the Elderly Chairperson: Michael J. Tueth, M.D. .
IW42. Issues in Tobacco Use and Schizophrenia Chairperson: Peter E. Cook, M.D. .
IW43. Cultural Issues in Consultation-Liaison Psychiatry Co-Chairpersons: Jon M. Streltzer, M.D., and Wen-Shing Tseng, M.D. .
IW44. Management of Sexual Predators After the Supreme Court Ruling in Kansas vs. Hendricks Chairperson: James E. Dillon, M.D. .
IW45. Academic Medical Centers Managing Care Chairperson: Arthur L. Lazarus, M.D., M.B.A. .
IW46. International Perspectives on Gay Psychiatry Co-Chairpersons: Gene A. Nakajima, M.D., and Siegmund Dannecker, M.D. .
IW47. How to Help Your Patients Stop Smoking Collaborative Session With the National Institute on Drug Abuse Co-Chairpersons: John R. Hughes, M.D., and Susan J. Fiester, M.D. .
IW48. Pharmacotherapy of Addictive Disorders Chairperson: Norman S. Miller, M.D.
.

9 a.m.-1 p.m.

Media Session

Session 10. Computerized Medical Records/Practice Management Software: Part I
14. Practice Management Software on the Cheap!
15. Computer Psychiatric Record Creation and Use for Solo Psychiatrists
16. Psych Script: Software to Create Typed Psych Notes

9 a.m.-11 a.m.

Media Sessions

Session 11. Diversity: A Case for Minority Faculty 17. Shattering the Silences
Session 12. Urban and Rural Systems of Care for the Chronic Mentally Ill
18. Schizophrenia: The Community's Response
19. In Their Shoes: Community Mental Health in Texas
20. Never Too Far: Rural Outreach for Serious Mental Illness

Research Advances in Medicine
The Effects of Perinatal Exposure to Cocaine Collaborative Session With the National Institute on Drug Abuse Chairperson: Frances R. Levin, M.D. .

9 a.m.-Noon

AIDS Education Program
Clinical and Neuropsychiatric Dimensions of HIV Disease, Part I Cosponsored by the APA Commission on AIDS and APA Education Steering Committee on AIDS
A. AIDS and HIV Disease: A Medical Update Sharon Walmsley, M.D. .
B. Neuropsychiatric Manifestations and Their Treatments: A Review Mark H. Halman, M.D. .

Continuous Clinical Case Conference, Part II Chairperson: Lisa A. Mellman, M.D., on Psychotherapies in Residency Training (Open to APA members only.)

9 a.m.-12:30 p.m.

Review of Psychiatry, Part II: Psychopathology and Violent Crime
Chairperson: Andrew E. Skodol II, M.D. .
7. Violent Crime and Axis I Psychopathology James C. Beck, M.D. .
8. The Personalities of Murderers: Sadistic Personality Revisited Michael H. Stone, M.D. .
9. Violent Crime and Axis II Psychopathology Jeremy W. Coid, M.D. .
10. Biology of Aggression: Relevance to Crime Emil F. Coccaro, M.D. .
11. Psychopathology, Crime, and Law Paul S. Appelbaum, M.D. .

9 a.m.-4 p.m.

CME Courses 65-71

10 a.m.-6 p.m.

Exhibits Open

Publishers' Bookfair Open

APA Resource Center Open

11 a.m.-2 p.m.

Media Sessions
Session 13. Rape and Reconciliation
21. Rape: A Crime of War
22. Glimmer of Hope

Session 14. Family/Consumer Perspectives on Coping With Stigma
23. Conversations at the Carter Center: Coping With the Stigma of Mental Illness
24. Mental Illness: The Family's Story
25. I'm Still Here, the Truth About Schizophrenia: A Nonfiction Film

11 a.m.-12:30 p.m.

Discussion Groups
7. Roslyn Seligman, M.D., on Development and Psychopathology: Clinical Perspectives
8. Pedro Ruiz, M.D., on Cultural Psychiatry

Lectures
L12. The Dysfunctional Family as Moral Exemplar: Studying Genesis Rabbi Burton L. Visotzky, Part V of a Day of Creation, Continued.
L13. Violence Prevention: A Public Health Mandate to Save Our Children Deborah B. Prothrow-Stith, M.D., APA's Solomon Carter Fuller Award Lecture .
L14. Educational Imperative: A Unified Psychotherapy Curriculum James H. Shore, M.D., APA's Seymour D. Vestermark Award Lecture.

Master Educator Clinical Consultations
7. Donald W. Black, M.D., on OCD and the Obsessive-Compulsive Spectrum (Open to APA members only.) 8. Eugene V. Beresin, M.D., on Anorexia and Bulimia Nervosa (Open to APA members only.) 9. Sheldon I. Miller, M.D. (Topic to Be Announced) Collaborative Session With the National Institute on Drug Abuse (Open to APA members only.)

Medical Update 2.
Richard P. Brown, M.D., on Herbal Medicine

Research Consultation With
1. Jerome H. Jaffe, M.D. (Topic to be announced) Collaborative Session With the National Institute on Drug Abuse

Scientific and Clinical Report Sessions
Session 11. The Spectrum of Substance Abuse: Research From the Brain to the Streets
32. Psychopathology and the Risk of Homelessness Carol L. M. Caton, Ph.D.
33. Addiction Professionals' Perception of Nicotine Use Baljit S. Gill, M.D. .
34. Mu-Opioid Receptor Binding During Cocaine Abstinence David A. Gorelick, M.D. Collaborative Session With the National Institute on Drug Abuse

Session 12. Complications in the Treatment of Mood Disorders
35. Relapse Following Discontinuation of Lithium Maintenance in Pregnant Women With Bipolar Disorder Adele C. Viguera, M.D. .
36. Tricyclic Antidepressant Overdoses: Time Trends Bentson H. McFarland, M.D. .
37. Clinical Effectiveness of Citalopran in Major Depression Dory G. Hachem, M.D. .

Session 13. The Somatic Spectrum
38. Effects of Trauma Events in GAD Patients Olga Brawman-Mintzer, M.D. .
39. Chronic Pain Disorder Following Injury Jon M. Streltzer, M.D. .
40. A Family Study of Fibromyalgia Catherine L. Woodman, M.D. .

Session 14. Risk Factors for Childhood Psychopathology
41. Some Long-Term Consequences of Orphanage Care John J. Sigal, Ph.D. .
42. Attachment Security of Mothers and Adolescents Elsie R. Broussard, M.D. .
43. Shyness and Behavioral Inhibition: Relationship to Anxiety Disorders Michael A. Van Ameringen, M.D. .

Session 15. Mental Health Delivery Issues
44. Maximizing Community Resources in a Rural Setting Janet E. Ordway, M.D. .
45. Managed Care Principles Applied to Indigent Mental Health Care F. Kevin Butler, M.D.
. 46. Integrating Physical Rehabilitation Services Into an Inpatient Psychiatric Unit Edward M. Phillips, M.D. .

Session 16. Biological Studies of Mental Illness
47. PET Analysis of Antidepressant Effects of Paroxetine Sidney H. Kennedy, M.D. .

10 a.m.-6 p.m.

Exhibits Open

Publishers' Bookfair Open

APA Resource Center Open

11 a.m.-2 p.m.

Media Sessions
Session 13. Rape and Reconciliation 21. Rape: A Crime of War 22. Glimmer of Hope
Session 14. Family/Consumer Perspectives on Coping With Stigma
23. Conversations at the Carter Center: Coping With the Stigma of Mental Illness
24. Mental Illness: The Family's Story
25. I'm Still Here, the Truth About Schizophrenia: A Nonfiction Film

11 a.m.-12:30 p.m.

Discussion Groups
7. Roslyn Seligman, M.D., on Development and Psychopathology: Clinical Perspectives
8. Pedro Ruiz, M.D., on Cultural Psychiatry

Lectures
L12. The Dysfunctional Family as Moral Exemplar: Studying Genesis Rabbi Burton L. Visotzky, Part V of a Day of Creation, Continued.
L13. Violence Prevention: A Public Health Mandate to Save Our Children Deborah B. Prothrow-Stith, M.D., APA's Solomon Carter Fuller Award Lecture .
L14. Educational Imperative: A Unified Psychotherapy Curriculum James H. Shore, M.D., APA's Seymour D. Vestermark Award Lecture.

Master Educator Clinical Consultations
7. Donald W. Black, M.D. on OCD and the Obsessive-Compulsive Spectrum (Open to APA members only.) 8. . Eugene V. Beresin, M.D., on Anorexia and Bulimia Nervosa (Open to APA members only.) 9. . Sheldon I. Miller, M.D. (Topic to Be Announced) Collaborative Session With the National Institute on Drug Abuse (Open to APA members only.)

Medical Update 2.
Richard P. Brown, M.D., on Herbal Medicine

Research Consultation With
1. Jerome H. Jaffe, M.D. (Topic to be announced) Collaborative Session With the National Institute on Drug Abuse

Scientific and Clinical Report Sessions
Session 11. The Spectrum of Substance Abuse: Research From the Brain to the Streets
32. Psychopathology and the Risk of Homelessness . Carol L. M. Caton, Ph.D. .
33. Addiction Professionals' Perception of Nicotine Use . Baljit S. Gill, M.D. .
34. Mu-Opioid Receptor Binding During Cocaine Abstinence. David A. Gorelick, M.D. Collaborative Session With the National Institute on Drug Abuse
Session 12. Complications in the Treatment of Mood Disorders
35. Relapse Following Discontinuation of Lithium Maintenance in Pregnant Women With Bipolar Disorder Adele C. Viguera, M.D. 36. Tricyclic Antidepressant Overdoses: Time Trends Bentson H. McFarland, M.D. .
37. Clinical Effectiveness of Citalopran in Major Depression Dory G. Hachem, M.D. .

Session 13. The Somatic Spectrum
38. Effects of Trauma Events in GAD Patients Olga Brawman-Mintzer, M.D. .
39. Chronic Pain Disorder Following Injury Jon M. Streltzer, M.D. .
40. A Family Study of Fibromyalgia Catherine L. Woodman, M.D. .

Session 14. Risk Factors for Childhood Psychopathology
41. Some Long-Term Consequences of Orphanage Care John J. Sigal, Ph.D. .
42. Attachment Security of Mothers and Adolescents Elsie R. Broussard, M.D. .
43. Shyness and Behavioral Inhibition: Relationship to Anxiety Disorders Michael A. Van Ameringen, M.D. .

Session 15. Mental Health Delivery Issues
44. Maximizing Community Resources in a Rural Setting Janet E. Ordway, M.D. .
45. Managed Care Principles Applied to Indigent Mental Health Care F. Kevin Butler, M.D. .
46. Integrating Physical Rehabilitation Services Into an Inpatient Psychiatric Unit Edward M. Phillips, M.D. .

Session 16. Biological Studies of Mental Illness
47. PET Analysis of Antidepressant Effects of Paroxetine Sidney H. Kennedy, M.D. .
48. Abnormal Diurnal 5-HIAA With Premenstrual Syndrome and Premenstrual Dysphoric Disorder Anita L.H. Clayton, M.D. .
49. Expanding Versus Static Ventricle Schizophrenia David L. Garver, M.D. .

Session 17. Innovations in Primary Care
50. Use of the PRIME-MD in a University Student Health Service Elizabeth H. Rand, M.D. .
51. Telepsychiatry in Georgia: A Multichanneled Approach Rhonda G. Vought, M.D. .
52. Care Models Guide Primary Care Psychiatry Teaching Troy L. Thompson II, M.D. .

Session 18. New Issues With Atypical Antipsychotics
53. Olanzapine Versus Placebo in the Treatment of Acute Mania Mauricio Tohen, M.D. .
54. Olanzapine Versus Risperidone and Haloperidol in the Treatment of Schizophrenia Barry Jones.
55. The Differential Risk of Tardive Dyskinesia With Olanzapine Charles M. Beasley Jr., M.D. .

Session 19. Geriatric Psychiatry
56. Clinical Response to Valproate in Geriatric Patients Julie A. Niedermier, M.D. .
57. Nortriptyline for Grief-Related Depression in Elders Mark D. Miller, M.D. .
58. Two-Year Outcome of Psychotic Depression in Late Life Alastair J. Flint, M.B. .

Component Workshops
CW28. OCD: Spanish Perspective APA Committee of Hispanic Psychiatrists Chairperson: Silvia W. Olarte, M.D. .
CW29. Promises and Problems With New Treatments for HIV APA New York County District Branch's AIDS Committee Co-Chairpersons: Elizabeth V. Getter, M.D., and John A. Sahs, M.D. .
CW30. Psychiatry Fellowships: Resident to Resident APA New York County District Branch's Residents Committee Chairperson: Evaristo O. Akerele, M.D. .
CW31. Film Clubs: How to Have Fun While Learning PsychiatryAPA Media Subcommittee Co-Chairpersons: Francis G. Lu, M.D., and Steven E. Hyler, M.D. .
CW32. Patients' Rights: An International Perspective APA Committee on International Abuse of Psychiatry and Psychiatrists Chairperson: Alan L. Gordon, M.D. .
CW33. Psychiatry and the Pharmaceutical Industry APA Joint Commission on Public Affairs Chairperson: Nada L. Stotland, M.D. .
CW34. Changing Psychiatric Compensation APA Committee on Psychiatric Administration and Management Co-Chairpersons: Carmel A. Foley, M.D., and Philip E. Veenhuis, M.D. .
CW35. Hot Off the Press: New Guidelines for Jails and Prisons APA Task Force to Revise the APA Report on Jails and Prisons Chairperson: Henry C. Weinstein, M.D. .
CW36. Effective Psychiatric Work in the Juvenile Justice System APA Committee on Juvenile Justice Issues Chairperson: Wade C. Myers, M.D. .

Issue Workshops
IW49. The Role of Enactment in Psychiatric Treatment Co-Chairpersons: Eric M. Plakun, M.D., and Edward R. Shapiro, M.D.
. IW50. Conceptualization and Boundaries of Trauma Chairperson: Malkah T. Notman, M.D. .
IW51. Sexual Activity in Long-Term Psychiatric Facilities Chairperson: Thomas P. Welch, M.D. .
IW52. How to Write and Publish in Psychiatry Chairperson: Carol C. Nadelson, M.D. .
IW53. George Gershwin at 100: A Creative Genius Re-Examined Chairperson: Richard Kogan, M.D. .
IW54. Art and Audience: The Creative Interaction Chairperson: Albert Rothenberg, M.D. .
IW55. Toning and Chanting: Accessing and Expressing the Nonverbal Co-Chairpersons: Leah J. Dickstein, M.D., and Alice H. Cash, Ph.D. .
IW56. Severe Mental Illness in Family Medicine Settings Chairperson: Rebecca S. Lewin, M.D. .
IW57. Transgender Issues Chairperson: Dan H. Karasic, M.D.
. IW58. Acupuncture, Oriental Medicine, and Psychiatry Chairperson: Antoinette W. Jakobi, M.D. .
IW59. Women's Issues in Drug Abuse: Violence, Trauma, and Victimization Collaborative Session With the National Institute on Drug Abuse Chairperson: Kathleen T. Brady, M.D. .
IW60. Transgender Awareness Chairperson: David E. Seil, M.D. .
IW61. Behavioral Independent Provider Association: A Look at the Future? Chairperson: Bruce J. Schwartz, M.D. .

Noon-1:30 p.m.

Forums
3. Psychiatry: 25 Years Since Depathologizing Homosexuality Chairperson: Lowell D. Tong, M.D. .
4. Toward a Neurobiology of Psychotherapy APA Commission on Psychotherapy by Psychiatrists Chairperson: Bernard D. Beitman, M.D. .
5. The Future of the Psychiatric Workforce Chairperson: Allan Tasman, M.D. .
6. Challenges in Teaching Psychiatry in the Next Century APA's George Tarjan Award Chairperson: Richard Balon, M.D. .

Noon-2 p.m.

New Research Poster Session

1 p.m.-5 p.m.

CME Courses 72-76

Media Session
Session 15. Computerized Medical Records/Practice Management Software: Part II
26. Comprehensive Clinician's Desktop
27. An Electronic Medical Record for Psychiatry
28. Computer-Assisted Service Planning

2 p.m.-3:30 p.m.

Lectures
L15. To Be Announced Sherwin B. Nuland, M.D., Part II of a Day of Creation.
L16. Dr. Alexandra Symonds' Legacy of Advancing Women Psychiatrists and Promoting Women's Mental Health: Sailing Toward the Next Millennium Leah J. Dickstein, M.D., APA's Alexandra Symonds Award Lecture .
L17. The Surprising Efficacy of Treatments for Addictive Disorders Charles P. O'Brien, M.D., Distinguished Psychiatrist Lecture Series Collaborative Session With the National Institute on Drug Abuse L18. Schizophrenia, Dopamine Receptors, and Antipsychotic Drugs Philip Seeman, M.D., Frontiers of Science Lecture Series

2 p.m.-5 p.m.

Media Sessions
Session 16. Innovative Teaching of Psychopathology
29. Paranoia
30. Step on a Crack
31. Deception: Munchausen's Disorder
32. Turning the Tables

Session 17. Film and Healing: Hope Arising From Despair
33. Contact

2 p.m.-5:30 p.m.

Review of Psychiatry, Part III: Psychobiology of Personality Disorders
Chairperson: Kenneth R. Silk, M.D. .
12. Genetics and Psychobiology of the Seven-Factor Model of Personality C. Robert Cloninger, M.D. .
13. Psychopharmacologic Management of Personality Disorders: An Outcome- Focused Model Paul S. Links, M.D. .
14. The Significance of Biological Research for a Biopsychosocial Model of Personality Disorders Joel F. Paris, M.D. .
15. New Strategies for Psychobiologic Investigation Larry J. Siever, M.D. .

2 p.m.-5 p.m.

Symposia
S24. Gender Issues in Cancer Treatment
A. Adolescents With Cancer: Gender and Intimacy Daniel Shapiro, Ph.D.
B. Counseling Men With Testicular and Prostate Cancer Patricia P. Rieker, Ph.D. .
C. Sequelae of Treatment in Women's Cancers Debra L. Fertig, M.D. .
D. Group Therapy That Narrows the Gender Gap Genevieve A. Mason, M.S.W. .
E. Gender Aspects of Marital Strain in Oncology John R. Peteet, M.D. .

S25. Conundrums of Comorbidity Collaborative Session With the National Institute on Drug Abuse
A. Treatment of PTSD and Substance Use Disorders Kathleen T. Brady, M.D. .
B. Evaluation of Depression in Substance Abusers David M. McDowell, M.D. .
C. Diagnosis and Treatment of Substance Abusers With ADHD Frances R. Levin, M.D. .
D. Overcoming Obstacles for Treating Dual Disorders Andrew L. Shaner, M.D. .
E. Comorbidity and Outcomes in Substance Abusers John S. Cacciola, Ph.D. .

S26. Controversy in Correctional Psychiatry
A. Mental Illness and Delinquency Norman E. Alessi, M.D. .
B. Implications of Mandatory Statutes Peter Ash, M.D. .
C. Punk Prisons and Juvenile Justice Reform Lee H. Rome, M.D. .
D. Psychiatry, Predators, and the Law Melvin Guyer, Ph.D., J.D. .
E. Implications of Sexual Predator Laws Lee H. Rome, M.D. .
F. Treatment of Sexual Predators After the Supreme Court Ruling on Kansas Versus Hendricks Gene G. Abel, M.D. .
G. Criminalization of the Mentally Ill: Is It Such a Bad Idea? James E. Dillon, M.D. .

S27. Emerging Trends in the Treatment of Dementia
A. Horizon Drugs and the Concept of Excess Disability Gary J. Kennedy, M.D. .
B. Estrogen Replacement Therapy for Dementia: Prophylaxis or Repair? Gary J. Kennedy, M.D. .
C. Cognitive Enhancers in the Clinic and on the Horizon Trey Sunderland, M.D. .
D. Antipsychotics in the Treatment of Dementia Complicated by Psychosis Davangere P. Devanand, M.D. .
E. Comorbidity of Depression in Dementia Patricia Parmelee, Ph.D. .

S28. The Changing Role of Psychiatrists in the Hospital APA Consultation Service Board
A. The Changing Role of Clinicians in Hospitals Benjamin Liptzin, M.D. .
B. Employee to Partner: Hospital Psychiatrist in Transition Steven S. Sharfstein, M.D. .
C. The Psychiatrist as Employer and Academician Sheldon I. Miller, M.D. .
D. The Psychiatrist as Employer or Organization Man Peter J. Panzarino Jr., M.D. .
E. The Psychiatrist as Teacher Robert Michels, M.D. .

S29. Biological Rhythms: New Frontier for Psychiatry
A. Seasonality of Mood and Related Symptoms Anthony J. Levitt, M.D. .
B. Circadian Alterations in Premenstrual Dysphoric Disorder Barbara L. Parry, M.D. .
C. Serotonin and SAD: Implications for Treatment Raymond W. Lam, M.D. .
D. Shifting Circadian Phase Using Light and Melatonin Alfred J. Lewy, M.D. .
E. How Does Light Regulate Body and Brain? Dan A. Oren, M.D. .

S30. Family Violence and Psychiatry: Canada and the United States Joint Session With the United States Department of Justice and the APA Committee on Family Violence and Sexual Abuse
A. Canadian Law: Psychiatry and Family Violence Prof. Alison Harvison Young.
B. United States Legal Reforms on Child and Family Violence Howard A. Davison, J.D. .
C. Child Abuse: A Review of Canadian Studies David A. Wolfe, Ph.D. .
D. United States Treatment Outcome Studies William M. Friedrich, Ph.D. .
E. Funding for the Family Violence Service in the United States: Office for Crime Victims Carolyn A. Hightower.
F. Funding for the Violence Service in Canada: CAVEAT (Canadians Against Violence Everywhere Advocating Its Termination) Dr. Priscilla De Villiers, M.S.M. .

S31. Models of Managed Care in the Public Sector APA Consortium on Organized Service Systems
A. Maryland's Public Mental Health System Billy E. Jones, M.D. .
B. SALUD! A Hybrid Model of Managed Care for New Mexico Mental Health James M. Jacobson, M.D. .
C. Carveouts for Behavioral Health Care: Trend or Pass�? C. Richard Orndoff, M.Ed. .
D. Psychiatrists as Managers in Public Sector Partnerships Ivan C.A. Walks, M.D. .
E. Models of Managed Care in the Public Sector Kurt A. Patton, M.S. .

S32. Multidimensional Assessment of Health
A. International Perspectives on Health Assessment Juan E. Mezzich, M.D. .
B. Comprehensive Nosology and Health Rachel Jenkins, M.D. .
C. Systematizing the Assessment of Psychopathology Andrew E. Skodol II, M.D. .
D. Assessment of Functioning and the International Classification of Impairments, Disabilities, and Handicaps Framework T. Bedirhan Ustun, M.D. .
E. The Appraisal of Social Context Marianne C. Kastrup, M.D. .
F. Quality of Life in Health Assessment Helen E. Herrman, M.D. .

S33. Complexity of Bipolar Disorder
A. Toward an Animal Model of Bipolar Disorder Aimee R. Mayeda, M.D. .
B. Recent Genetic Findings in Bipolar Disorder John I. Nurnberger Jr., M.D. .
C. Ethnic Issues in Bipolar Disorder William B. Lawson, M.D. .
D. The New Uses for Valproic Acid Samuel O. Okpaku, M.D. .

S34. Affective Dysfunctions in Schizophrenia Joint Session With the World Psychiatric Association and the German Society of Psychiatry, Psychotherapy, and Nervous Diseases
A. Affective Dysfunctions: Concepts and Assessment Wolfgang Woelwer, Ph.D. .
B. Affective and Neuromotor Deficits in Schizophrenia: What's What? Robert H. Dworkin, Ph.D. .
C. Brain Mechanisms of Affective and Social Behaviors John F.W. Deakin.
D. Brain Mechanisms of Affective Disorder in Schizophrenia Peter F. Liddle, M.D. .
E. Affective Dysfunctions in Schizophrenia: Treatment Strategies Prof. Dr. Hans D. Brenner.

S35. Dealing With Psychopathy: The United States Supreme Court's Kansas vs. Hendricks Decision and Beyond
A. Don Juan: Myths, Milestones, and Management of the Paraphilias John M.W. Bradford, M.B. .
B. Psychopathy as a Risk Factor for Violence Robert D. Hare, Ph.D. .
C. The Aggressive Patient: Beyond Denial Gary J. Maier, M.D. .
D. Mad Versus Bad Revisited: Managing Predatory Behavior William M. Tucker, M.D. .

S36. Recent Findings in Social Phobia
A. Diagnostic and Assessment Issues Richard G. Heimberg, Ph.D. .
B. Epidemiology, Morbidity, Comorbidity, and Disability Murray B. Stein, M.D. .
C. Recent Psychological Findings in Social Phobia Franklin R. Schneier, M.D. .
D. Familial and Temperamental Factors in Social Phobia Abby J. Fyer, M.D. .
E. Treatment of Social Phobia Michael R. Liebowitz, M.D. .
F. The Offensive Type of Social Phobia: Cross-Cultural Perspectives Si-Hyung Lee, M.D. .

S37. Psychotherapeutic Issues in Psychiatric Care Joint Session With the American Psychoanalytic Association
A. Psychotherapeutic Issues in Medication Management Allan Tasman, M.D. .
B. Psychodynamic Psychotherapy of Panic Disorder Barbara L. Milrod, M.D. .
C. Psychotherapy in Managing the Medically Ill David Spiegel, M.D. .
D. Psychotherapeutic Modalities in the Treatment of PTSD Melvin R. Lansky, M.D. .
E. Dynamic Therapy in the Treatment of Depression Glen O. Gabbard, M.D. .

S38. Psychosocial Interventions for Drug Abuse Collaborative Session With the National Institute on Drug Abuse
A. Contingency-Management Therapy With Drug Abusers Stephen T. Higgins, Ph.D. .
B. Therapy for Borderline Personality and Drug Abuse Marsha M. Linehan, Ph.D. .
C. Efficacy of Psychosocial Services for Drug Abuse Thomas McLellan, Ph.D. .
D. Behavioral Couples Therapy for Substance Abuse Timothy J. O'Farrell, Ph.D. .
E. Structured Psychotherapies for Drug Abuse Bruce J. Rounsaville, M.D. .

S39. Harvard Psychopharmacology Expert Systems Project
A. Inventing an Information Support System Robert D. Patterson, M.D. .
B. Psychopharmacology of Depression Expert System David N. Osser, M.D. .
C. Psychopharmacology of Psychosis Expert System Carlos A. Zarate Jr., M.D. .
D. Anxiety in Patients With Chemical Abuse and/or Dependence Rogelio D. Bayog, M.D. .
E. Psychopharmacological Algorithms: Mental Retardation Edwin J. Mikkelsen, M.D. .

S40. Medical Marijuana: Options and Problems Joint Session With the American Academy of Addiction Psychiatry
A. The Pharmacology and Clinical Pharmacology of Marijuana Claudio A. Naranjo, M.D. .
B. Medical Marijuana and Drug Policy Reform Ethan A. Nadelmann, Ph.D., J.D. .
C. Marijuana: Still a Signal of Misunderstanding J. Thomas Ungerleider, M.D. .
D. Compassion or Contradiction? Marijuana as a Medicine John Mendelson, M.D. .
E. Adverse Effects of Marijuana: Do These Limit Medical Use? Robert B. Millman, M.D. .

S41. Practicing Evidence-Based Psychiatry: MDD
A. Major Depressive Disorder: Using Psychiatric Measures in Clinical Care Kimberly A. Yonkers, M.D. .
B. Clinical Practice Guidelines for Treatment T. Byram Karasu, M.D. .
C. What's Really Going on in the Treatment of MDD? Mark Olfson, M.D. .

S42. New Insights on Bipolar Disorder
A. Bipolar Mood Disorder: Overview of Illness and Management Gary S. Sachs, M.D. .
B. Novel Treatment Strategies for Refractory Bipolar Disorder Andrew L. Stoll, M.D. .
C. Child and Adolescent Bipolar Disorder: A Review Ronald J. Steingard, M.D. .
D. MRS Studies of Brain Chemistry in Bipolar Disorder Perry F. Renshaw, M.D. .

S43. Etiology of Eating Disorders: High-Risk Groups
A. Epidemiologic Studies of Eating Disorders Paul E. Garfinkel, M.D. .
B. Eating Disorders and Sexual Abuse: What Is the Link? Janet M. deGroot, M.D. .
C. Compulsive Exercising as a Risk for Eating Disorders Caroline A. Davis, Ph.D. .
D. The Relationship Between Obesity and Eating Disorders Allan S. Kaplan, M.D. .
E. Eating Disorders in Gay Males: Double Stigma Arnold E. Andersen, M.D. .
F. Eating Disorders and Diabetes: Iatrogenic? Gary M. Rodin, M.D. .

S44. Devastating Effects of Childhood Abuse on Mind and Brain
A. Clinical Presentation of Dissociative Disorders Related to Abuse Dorothy O. Lewis, M.D. .
B. Effects of Childhood Abuse on Psychopathology and Brain Anatomy J. Douglas Bremner, M.D. .
C. The Neuro-Archeology of Child Abuse and Neglect: Use and Disuse of Dependent Neurodevelopment Bruce D. Perry, M.D. .
D. Stressor Reactivity in Abused and Nonabused Girls Frank W. Putnam Jr., M.D. .
E. Childhood and Other Traumas in the Etiology of Depression Carolyn M. Mazure, Ph.D. .

S45. Neuroanatomy of Normal and Pathological Emotion
A. Neural Correlates of Normal Human Emotion Richard D. Lane, M.D. .
B. Mood Lateralization: Transcranial Magnetic Stimulation Mark S. George, M.D. .
C. Anatomical Correlates of Familial Mood Disorders Wayne C. Drevets, M.D. .
D. Functional Neuroimaging Studies in Anxiety Disorders Scott L. Rauch, M.D. .

S46. Recognition, Management, and Reporting of Drug-Induced Disease: A Clinical Pharmacologic Approach for Psychiatrists
A. Premarketing Drug Safety Evaluation Thomas P. Laughren, M.D. .
B. Drug-Induced Disease: Pharmacokinetic and Pharmacodynamic Consideration John D. Balian, M.D. .
C. Clinical Assessment, Workup, and Reporting of Adverse Drug Events Stephen A. Goldman, M.D. .

S47. Schizophrenia: A Neurodevelopmental Perspective
A. Prenatal Rubella and Adult Schizophrenia Alan S. Brown, M.D. .
B. Neurohormonal and Behavioral Change in Schizotypal Adolescents Elaine F. Walker, Ph.D. .
C. Genes, Prenatal Factors, and IQ of Offspring at High Risk for Psychosis Jill M. Goldstein, Ph.D. .
D. A Rat Model of Schizophrenia: Neonatal Hippocampal Damage Barbara K. Lipska, Ph.D. .
E. Low Specificity for Developmental Precursors of Psychosis Peter B. Jones, Ph.D. .

S48. Management of Schizophrenia With Comorbid Disorders
A. Management of Comorbid Depression in Schizophrenia Samuel G. Siris, M.D. .
B. Management of Obsessive-Compulsive Patients With Schizophrenia Michael Y. Hwang, M.D. .
C. Violence in Schizophrenia Leslie L. Citrome, M.D. .
D. Management of Cognitive Impairment in Schizophrenia Dilip V. Jeste, M.D. .

S49. Single Payer or Competition? Canadian and United States Views
A. Canada's Single Payer System Arthur L. Lesser, M.D. .
B. Why a Private Alternative Is Essential Joseph Berger, M.B. .
C. Advantages of Single Payer System Captane P. Thomson, M.D. .
D. Managed Care Versus Medical Savings Accounts: Fact and Fiction Frederick K. Goodwin, M.D. .

S50. Pharmacological Treatments in Schizophrenia and Their Effect on Cognitive Function
A. Cognition and Atypical Antipsychotics in Schizophrenia Richard S.E. Keefe, Ph.D.
. B. Effects of Clozapine on Cognition in Schizophrenia Larry J. Seidman, Ph.D. .
C. Effect of Risperidone on Cognitive Function in Schizophrenia Ileana Berman, M.D. .
D. Effects of Glutamatergic Agents on Cognitive Function Donald C. Goff, M.D. .

S51. Early Detection and the Treatment of First Psychosis
A. The TIPS Project: An International Multicenter Site for Early Detection Per Vaglum, M.D. .
B. Early Detection in the Experimental Sector Jan Olav Johannessen, M.D. .
C. TIPS: The Norwegian Comparison Site, Ullevaal Hospital Ingrid Melle, M.D. .
D. TIPS: The Danish Comparison Site, Roskilde County, Denmark Erik Simonsen, M.D. .
E. Duration of Untreated Psychosis: Can It Be Reduced? Tor Kjetl Larsen, M.D. .
F. Family Intervention in Prodromal and Early Psychosis William R. McFarlane, M.D. .

3 p.m.-5 p.m.

New Research Poster Session

7 p.m.-10 p.m.

Industry-Supported Symposia
IS35. Pharmacotherapy Combination Strategies in Clinical Practice Supported by Janssen Pharmaceutica and Research Foundation
A. Skillful Polypharmacy Is the Current Practice Devdutt V. Nayak, M.D. .
B. Clinical Strategies in Intractable Depression Jan A. Fawcett, M.D. .
C. Rational Copharmacy for Bipolar Disorder Philip G. Janicak, M.D. .
D. Copharmacy in Treatment-Resistant Anxiety States Michael R. Liebowitz, M.D. .
E. Treatment of Drug-Refractory Schizophrenia Sidney Fein, M.D. .

IS36. Hot Topics in Alzheimer's Disease Supported by Bayer Pharmaceuticals
A. Apolipoprotein E-e4 and Alzheimer's Disease: Search for Truth Kathleen Welsh-Bohmer, Ph.D. .
B. Diagnostic Testing: Benefits or Just Costs? Gary W. Small, M.D. .
C. Prevention of Alzheimer's Disease: NSAID's, Estrogens, and H2 Blockers John C.S. Breitner, M.D. .
D. Antioxidants in Selegiline: Are They Ready for the Clinic? Pierre N. Tariot, M.D. .
E. Cholinesterase Inhibitors: Greater Therapeutic Possibilities? Martin R. Farlow, M.D. .

IS37. Update on Diagnosis: Pathophysiology and Treatment of Primary Headache Disorders for the Practicing Psychiatrist Supported by Merck U.S. Human Health.
A. Epidemiology and Comorbidity of Primary Headache Disorders Richard B. Lipton, M.D. .
B. The Diagnosis and Classification of Primary Headache Disorders Alan M. Rapoport, M.D. .
C. Pathophysiology of Primary Headache Ninan T. Mathew, M.D. .
D. Pharmacologic Treatment of Primary Headache Disorders Joel Saper, M.D. .
E. Menstrual and Menopausal Migraine Ivy Fettes, M.D. .
F. Behavioral and Psychophysiological Approaches to Primary Headache Disorders Steven M. Baskin, Ph.D. .

IS38. Exploring the Course of Schizophrenia Supported by Pfizer U.S. Pharmaceutical.
s A. Rapidly Controlling Acute Psychotic Symptoms With Antipsychotic Drugs William C. Wirshing, M.D. .
B. Relapse Prevention John M. Kane, M.D. .
C. Long-Term Studies in Schizophrenia: Improving Functional Outcomes Mihaly Arato, M.D. .
D. Assessment and Treatment of Depression in Schizophrenia Donald E. Addington, M.D. .
E. Adverse Effects Profile of New Antipsychotic Agents Daniel E. Casey, M.D. .

IS39. Clinical Challenges in the Treatment of Depression Subtypes Supported by Solvay Pharmaceuticals Inc. and Pharmacia & Upjohn Company Inc. .
A. Minor and Subsyndromal Depression and Their Treatment Mark H. Rapaport, M.D. .
B. Dysthymic Disorder David L. Dunner, M.D. .
C. Anxious Depression: Treatment Approaches Maurizio Fava, M.D. .
D. Depression With Alcohol and/or Drug Abuse Patrick J. McGrath, M.D. .
E. Psychotic Depression Barbara Hochstrasser, M.D. .

IS40. Recent Advances in Psychopharmacology Joint Session With the American Society of Clinical Psychopharmacology, Inc. Supported by Abbott Laboratories.
A. New Treatments for Schizophrenia Carol A. Tamminga, M.D. .
B. Anticonvulsants in Bipolar Disorder Joseph R. Calabrese, M.D. .
C. Treatment of Chronic Depression James H. Kocsis, M.D. .
D. Current Treatments for Eating Disorders B. Timothy Walsh, M.D. .
E. Advances in Geriatric Psychiatry J. Craig Nelson, M.D. .

IS41. Treating the Difficult-to-Treat Depressed Patient Supported by Forest Laboratories Inc. .
A. When the Depressed Patient Is Not Responding Steven P. Roose, M.D. .
B. Antidepressant Use in Patients With Heart Disease Alexander H. Glassman, M.D. .
C. Treatment of Depression With Comorbid Personality Disorders Glen O. Gabbard, M.D. .
D. Estrogens and Progestins: Do They Cause or Treat Mood Disorders? Kimberly A. Yonkers, M.D. .
E. Treatment of Depressed Patients With Cognitive Impairment Carl G. Gottfries, Ph.D. .

Media Sessions
Session 18. Violence Against Women
34. Responses in Music to Violence Against Women
35. Packing Heat

Session 19. Substance Abuse in Youth: A British Perspective Collaborative Session With the National Institute on Drug Abuse
36. Trainspotting

Symposia
S52. A Worldwide Challenge: World Psychiatric Association's Responses
A. World Psychiatric Association Educational Programs in the Czech Republic: A Model Jiri Raboch, M.D. .
B. World Psychiatric Association Educational Programs on Teaching and Learning About Schizophrenia Driss Moussaoui, M.D. .
C. A Worldwide Challenge: Education Efforts by the World Psychiatric Association Pedro Ruiz, M.D. .
D. International Guidelines for Diagnostic Assessment Juan E. Mezzich, M.D. .
E. ICD-10 for Psychiatrists and Primary Care Physicians Juan J. Lopez-Ibor Jr., Ph.D. .

S53. Culture and Ethnicity: An Arab Perspective Joint Session With the Arab-American Psychiatric Association
A. Ethnic and Cultural Influence in the Psychiatric Diagnosis Ossama T. Osman, M.D. .
B. Group Therapy: An Islamic Approach Osama M. Al-Radi, M.D. .
C. Ethnicity and Psychopharmacology Ahmed M.F. Okasha, M.D. .
D. Ethnicity and Transcultural Aspects of ECT Tarek A. Okasha, M.D. .
E. Educating Trainees to Care for Persons of Other Cultures Earl L. Loschen, M.D. .

S54. The Connections Between Gender and Victimhood APA Rhode Island Psychiatric Society's Committee on Women
A. The Exploration of the Concept of Victimhood in a Patriarchal Culture and the Consequences for Each Gender Alison M. Heru, M.D. .
B. Indo-Pakistani Women: The Captured Beings Neeta Jain, M.D. .
C. Women, Tobacco, Bondage, and Freedom Terry Halbert, J.D., M.D. .
D. Gender and the Medical Response Henrietta L. Leonard, M.D. .
E. Victimhood: The Role of Legal Interventions Patricia R. Recupero, M.D., J.D. .

S55. Military Mental Health
A. The Military Psychiatrist in Deployment Elspeth C. Ritchie, M.D. .
B. Mental Health in Primary Care: An Air Force Prototype Project Karl O. Moe, Ph.D. .
C. Confidentiality Issues in Military Medicine Joseph A. Procaccino Jr., J.D. .
D. Suicide Risk Reduction in the Air Force: A Community Prevention Karl O. Moe, Ph.D. .
E. Evolutions in Military Psychiatry Residency Training James R. Rundell, M.D. .

S56. Administrative Psychiatry: How Clinician Executives Can Survive These Turbulent Times!
A. An Overview of the Evolving Behavioral Health System Michael A. Freeman, M.D. .
B. Core Administrative Concepts Miles F. Shore, M.D. .
C. New Roles for Behavioral Health Players Judith Browne, R.N. .
D. How Selected Behavioral Health Systems Are Moving Toward Integration Jose M. Santiago, M.D. .
E. Law and Ethics Donald H. Williams, M.D. .
F. Future Issues for Administrative Psychiatry John A. Talbott, M.D. .

S57. Artists at Midlife: Confrontations With Death
A. The Midlife Crisis in Artists Elliott Jaques, M.D. .
B. Rembrandt at Midlife: St. Jerome in a Dark Chamber Joseph J. Schildkraut, M.D. .
C. Lord Byron: A Fevered Dying Kay R. Jamison, Ph.D. .
D. Arshile Gorky: Terminal Agonies and Abstract Expressionism Kareen Akiskal, B.A. .

S58. When Sports Goes Over the Line Joint Session With the International Society for Sport Psychiatry
A. Violence on and off the Field Antonia L. Baum, M.D. .
B. The Effects of Verbal Abuse in Sports Robert W. Burton, M.D. .
C. Athlete to Athlete Violence Ronald L. Kamm, M.D. .
D. Sports Torts: The Interplay of Our Legal and Sport Systems Mel Narol, Esq.